Metastases to liver and Infection

Summary:

Infection is found among people with Metastases to liver, especially for people who are female, 60+ old.

The study analyzes which people have Infection with Metastases to liver. It is created by eHealthMe based on reports of 60 people who have Metastases to liver from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastases to liver?

Metastases to liver (cancer spreads to liver) is found to be associated with 1,041 drugs and 999 conditions by eHealthMe. Check the latest studies of Metastases to liver.

What is Infection?

Infection is found to be associated with 2,505 drugs and 2,590 conditions by eHealthMe. Check the latest studies of Infection.



On Jul, 17, 2026

60 people who have Metastases To Liver and Infection are studied.

Would you have Infection when you have Metastases to liver?

Gender of people who have Metastases To Liver and experienced Infection *:

  • female: 53.19 %
  • male: 46.81 %

Age of people who have Metastases To Liver and experienced Infection *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.7800000000000002 %
  • 30-39: 2.7800000000000002 %
  • 40-49: 8.33 %
  • 50-59: 11.11 %
  • 60+: 75.0 %

Common co-existing conditions for these people *:

  1. Metastases To Bone (cancer spreads to bone): 12 people, 20.00%
  2. Metastases To Lymph Nodes (cancer spreads to lymph node): 10 people, 16.67%
  3. Metastases To Lung (cancer spreads to lung): 9 people, 15.00%
  4. Colon Cancer: 7 people, 11.67%
  5. High Blood Pressure: 4 people, 6.67%
  6. Nausea (feeling of having an urge to vomit): 4 people, 6.67%
  7. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 3 people, 5.00%
  8. Metastatic Gastric Cancer (cancer types can spread to the stomach from other place): 3 people, 5.00%
  9. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 5.00%
  10. Diabetes: 3 people, 5.00%

Common drugs taken by these people *:

  1. Zometa: 10 people, 16.67%
  2. Nifedipine: 10 people, 16.67%
  3. Synthroid: 9 people, 15.00%
  4. Zetia: 9 people, 15.00%
  5. Cymbalta: 9 people, 15.00%
  6. Furosemide: 9 people, 15.00%
  7. Zolpidem: 9 people, 15.00%
  8. Lisinopril: 9 people, 15.00%
  9. Peridex: 9 people, 15.00%
  10. Prempro: 9 people, 15.00%

Common symptoms for these people *:

  1. Rashes (redness): 12 people, 20.00%
  2. Back Pain: 12 people, 20.00%
  3. Haemorrhage (bleeding): 12 people, 20.00%
  4. Fever: 12 people, 20.00%
  5. High Blood Pressure: 11 people, 18.33%
  6. Neuropathy Peripheral (surface nerve damage): 11 people, 18.33%
  7. Depression: 10 people, 16.67%
  8. Intervertebral Disc Degeneration (spinal disc degeneration): 10 people, 16.67%
  9. Injury: 10 people, 16.67%
  10. Hypoaesthesia (reduced sense of touch or sensation): 10 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Infection?

- Check whether Infection is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Infection:

All the conditions that are associated with Infection:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Infection and Metastases to liver, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: